HIVST@orasure.com Phone: 011-44-7771-844456

About OraQuick^® HIV Self-Test (HIVST)

The OraQuick^® HIV Self-Test (HIVST) is a rapid, point-of-care test that allows an individual to detect antibodies to both HIV-1 and HIV-2 with a simple oral swab and provides a result in as little as 20 minutes in the privacy of an individual’s home, at outreach testing settings, in the pharmacy or at community based screening events.

Based on the same OraQuick^® platform that is used for the FDA-approved OraQuick In-Home HIV Test and the WHO Prequalified OraQuick Rapid HIV-1/2 Antibody Test used by health care professionals worldwide, the platform has been used to test millions.

What is the Bill and Melinda Gates Foundation agreement with OraSure Technologies?

The charitable support agreement with the Bill & Melinda Gates Foundation will enable OraSure to offer its OraQuick^® HIV Self Test at $2.00 per test in 50 developing countries. The funding will consist of support payments tied to the volume of product sold by OraSure. Pricing excludes freight, importation duties and taxes and in-country delivery costs, as required. The price applies to all public health testing initiatives but does not apply to the in-pharmacy retail version of the product.

Through this agreement, funding from the Gates Foundation will enable public sector procurement in eligible countries through governmental and non-governmental organizations.

What Countries are eligible to participate in the program?

How to use the OraQuick HIV Self-Test

Download Instructions

Interested in more information on pricing or implementation?

HIVST@orasure.com - +44 7771 844456

The information provided on this website is intended only for the residents of the U.S. The products discussed herein may have different labeling in different countries and may not be for sale in all other countries.